Showing results (41-50 of 396) with videos related to
Sort By:
Pageof 40
Melanoma Management|September 8, 2018
Oncogene-directed small molecule inhibitors for the treatment of cutaneous melanomaPhilip Eliades, Keith T Flaherty, Hensin TsaoMolecular Aspects of Medicine|February 24, 2010
Molecular therapeutic approaches to melanomaZhenyu Ji, Keith T Flaherty, Hensin TsaoClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2013
BRAF in melanoma: current strategies and future directionsApril K S Salama, Keith T FlahertyMolecular Oncology|March 12, 2011
Biological challenges of BRAF inhibitor therapyIgor Puzanov, Patrick Burnett, Keith T FlahertyTrends in Molecular Medicine|October 4, 2011
Targeting the RAS pathway in melanomaZhenyu Ji, Keith T Flaherty, Hensin TsaoNature Reviews. Clinical Oncology|April 11, 2019
Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathwaysXue Bai, David E Fisher, Keith T FlahertyHematology/Oncology Clinics of North America|July 6, 2024
Targeted Therapy Innovations for MelanomaDahiana Amarillo, Keith T Flaherty, Ryan J SullivanSeminars in Cutaneous Medicine and Surgery|August 3, 2014
Current status and future directions of molecularly targeted therapies and immunotherapies for melanomaDavid M Miller, Keith T Flaherty, Hensin TsaoAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Tissue-Agnostic Drug DevelopmentKeith T Flaherty, Dung T Le, Steven LemeryNature Reviews. Cancer|April 6, 2012
From genes to drugs: targeted strategies for melanomaKeith T Flaherty, F Stephen Hodi, David E FisherPageof 40